Skip to content

A Claret

Paris Brain Institute - Institut du cerveau (ICM), Sorbonne University/CNRS/Inserm, UMR 7225/UMRS 1127, Paris, France.

1 paper in the library · 7 citations · publishing 2022

Papers

[Ketamine Augmented Psychotherapy (KAP) in mood disorder: User guide].

L'Encephale June 1, 2022 H Bottemanne, A Baldacci, C Muller et al. 7 citations

Ketamine, a fast-acting antidepressant, produces dissociative effects and promotes brain plasticity. Although preliminary studies suggest combining it with psychotherapy may be beneficial, clinical antidepressant use rarely includes per- and post-infusion therapy. The psychodysleptic experiences and synaptogenic effects could enhance cognitive behavioral therapy. This article proposes a practical protocol for Ketamine Augmented Psychotherapy (KAP), synthesizing literature and clinical experience. It details four steps: preparation, administration, integration, and prolongation, and discusses limits and prospects for mood disorder management.